New diabetes clinical trial: A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

Published on: April 29, 2021 at 09:30PM
Conditions:   Diabetes Mellitus, Type 2;   Chronic Kidney Disease
Interventions:   Drug: Semaglutide;   Drug: Placebo (Semaglutide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3e0vmnf